Halozyme Therapeutics Inc

Financials

İşletme faaliyetlerinden elde edilen nakit 178.47 M154.22 M99.71 M178.6 M219.03 M 651.56 M Yatırım faaliyetlerinden elde edilen nakit 29.48 M-90.42 M84.79 M201.61 M-741.79 M -545.81 M Finansman faaliyetlerinden elde edilen nakit -246.41 M-3.32 M-298.97 M-22.4 M239.51 M -85.17 M Free cash flow 175.41 M153.27 M98.15 M175.57 M217.6 M 644.59 M

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

HALO

Financials

Halozyme Therapeutics Inc

Haberler

Travere (TVTX) Soars 37.2%: Is Further Upside Left in the Stock?

TD Cowen, Halozyme hissesi için Al tavsiyesini yineledi

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Halozyme Therapeutics CEO’su Helen Torley 634.981 dolar değerinde hisse sattı

Halozyme, Hypercon teknolojisini Vertex’e 15 milyon dolara lisansladı

Leerink, Vertex anlaşması sonrası Halozyme hisse notunu korudu

Leaderboard Trimmed, But Cloudflare, Caterpillar Among 5 Stocks To Watch

JNJ: Success In Multiple Myeloma Underpins $25B In Growth By 2030 (NYSE:JNJ)

Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?

Halozyme, David Ramsay’i geçici CFO olarak atadı

Halozyme names David Ramsay as interim CFO

Halozyme Citizens Life Sciences’ta: Stratejik Büyüme ve Yenilikler